Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?
Molecular testing has become an essential component of modern iCCA management. Broad, early, and technically integrated molecular profiling-ideally performed at initial diagnosis and interpreted in an interdisciplinary (molecular) tumor board-is critical to fully realize the potential of precision oncology in BTC.
Authors
- Michael Quante (ORCID: https://orcid.org/0000-0002-8497-582X)
- Maryam Barsch (ORCID: https://orcid.org/0000-0003-3983-8276)
- Anne M. Schultheis
- Elaine-Pashupati Dopfer
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
Publication Details
- Journal
- Journal of Gastrointestinal Cancer
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1007/s12029-026-01397-y
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 39.15